|
|
Current Research Projects
Brief overview of research
projects that are in progress in the Vascular Surgery Research Laboratory:
"Molecular Mechanisms of Aneurysmal Degeneration"
[NIH R01 HL56701-05, R.W. Thompson]. This program utilizes a mouse
model of aortic aneurysms to elucidate critical molecular pathways
in aneurysmal degeneration, principally through the use of genetically
altered mice. The principal focus is on chemotactic molecules related
to elastin and their receptors, and on various elastin-degrading
members of the matrix metalloproteinase (MMP) family. A second component
of the program is focused on delineating the molecular mechanisms
by which doxycycline influences inflammatory cell expression of
MMPs, using promoter-reporter constructs in cultured mononuclear
phagocytes.
"Molecular Pathophysiology of Abdominal Aortic Aneurysms:
Regulated Expression of Collagenases in AAA" [NIH
R01 HL64332-01, R.W. Thompson]. The purpose of this project is to
understand the factors regulating vascular smooth muscle cell (SMC)
expression of collageneases-1 and -3, two important members of the
MMP family. Studies involve immunohistochemistry and in situ hybridization
in human aneurysm tissues, and use of promoter-reporter constructs
in cultured human vascular SMC.
"Molecular Pathophysiology of Abdominal Aortic Aneurysms:
Aneurysm Research Core" (NIH R01 HL64333-01, R.W.
Thompson). This program supports a unique aneurysm research core
laboratory, which provides human aortic tissues and the use of small
animal models of aortic aneurysm to participating investigators
in the Washington University Aneurysm Research Center.
"Molecular Pathophysiology of Abdominal Aortic Aneurysms:
Oxidative Mechanisms" [NIH R01 HL64334-01, J. Heinecke].
This program utilizes sophisticated molecular analysis of human
and murine aortic tissues to elucidate how different pathways of
oxidative damage influence the development of aortic aneurysms.
Studies involve the use of novel molecular "footprints"
of oxidative damage, with a particular focus on MMPs and TIMPs,
and the application of genetically altered mice deficient in enzymes
specific to different oxidative pathways.
"Plasma MMP Levels in Patients with Aortic Aneurysms:
Effects of Disease Progression and Doxycycline Treatment"
[AHA Heartland Affiliate Research Grant-in-Aid 9951317Z, R.W. Thompson
and D.M. Hovsepian]. The purpose of this project is to determine
if plasma levels of MMP-9 can be used as biomarker of disease activity
in patients with aortic aneurysms, and to examine the effects of
treatment with doxycycline on plasma MMP-9 levels.
"Medical Interventions in the Management of Small Abdominal
Aortic Aneurysms-MIMOSA" [R.W. Thompson and B.T. Baxter].
This project is a multi-institutional prospective randomized clinical
trial intended to determine how treatment with doxycycline influences
the expansion rate of small asymptomatic abdominal aortic aneurysms.
"Applications of Web-Based Artificial Neural Networks
for the Diagnosis, Prognosis and Management of Abdominal Aortic
Aneurysms" [R.W. Thompson]. This project represents
a comprehensive computational approach to evaluate patients for
their risks of having an aortic aneurysm, as well as to predict
long-term outcomes for patients with aneurysms of all types. The
project includes development of a web-based interactive system to
provide information on aortic aneurysm disease, as well as for the
conduct of clinical trials.
"Immunomodulating Cytokines in Abdominal Aortic Aneurysms"
[P.J. Geraghty]. This program involves the use of human aortic tissues
and mouse model of aortic aneurysm to elucidate the role of immunomodulating
cytokines in aneurysmal degeneration.
"Mechanisms Underlying the Development of Ascending
Aortic Aneurysms" [T.M. Sundt, Ruth Okamoto, and R.W.
Thompson]. The purpose of this project is to examine how ascending
aortic aneurysms differ from those arising in the abdominal aorta,
particularly with respect to biochemical, morphological and biomechanical
features.
"Biomechanical Properties of the Aneurysmal Aorta"
[R.W. Thompson and R.P. Mecham]. This project involves quantitative
biomechanical analysis of the aorta from mice with elastase-induced
aneurysms, and how these features are influenced by targeted deletion
of specific genes involved in aneurysmal degeneration.
“Interaction of Integrin avb3 and Matrix Metalloproteinases
in Intimal Hyperplasia” (AHA Grant-in-Aid, E.T. Choi).
This project involves the use of the mouse model of intimal hyperplasia
to examine the role of a promiscuous integrin avb3 and its interaction
with matrix metalloproteinases in smooth muscle cell migration leading
to the development of intimal hyperplasia.
“Collagen-binding Integrins in Intimal Hyperplasia”
(NIH K08, E.T. Choi). This project involves the use of human arterial
tissues and mouse model of intimal hyperplasia to identify the smooth
muscle cell receptors that bind to collagen and mediate cellular
migration and proliferation on collagen leading to atherosclerosis
and intimal hyperplasia.
Washington University physicians are the medical staff of Barnes-Jewish Hospital and St. Louis Children's Hospital
|